Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Endometrial Cancer
Related studies linked through entity extraction aliases.
Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer
- Status
- RECRUITING
- Phase
- N/A
Hyperpolarized 13C MRI for Cancer Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
- Status
- RECRUITING
- Phase
- PHASE2
Predictors of Node Positivity in Endometrial Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Developing a MRI-based Deep Learning Model to Predict MMR Status
- Status
- UNKNOWN
- Phase
- N/A
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53
- Status
- UNKNOWN
- Phase
- N/A
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
- Status
- RECRUITING
- Phase
- NA
Adherence and Compliance to ERAS in Gynecological Surgery
- Status
- RECRUITING
- Phase
- N/A
Non-Invasive Diagnosis of Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA